LUKE EVNIN Insider Trading $PCRX Pacira BioSciences, Inc.
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is 10% Owner in VIACELL INC ($VIAC) and in CORNERSTONE THERAPEUTICS INC ($CRTX) and Director in METABASIS THERAPEUTICS INC ($MBRX) and in Pharmasset Inc ($VRUS) and 10% Owner in Pharmasset Inc ($VRUS) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and in Omrix Biopharmaceuticals, Inc. ($OMRI) and 10% Owner in Omrix Biopharmaceuticals, Inc. ($OMRI) and Director in Restore Medical, Inc. ($REST) and 10% Owner in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Epizyme, Inc. ($EPZM).
LUKE EVNIN in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKE EVNIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 13 2013
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LUKE EVNIN in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRTX, EPZM, HSTO, MBRX, OMRI, PCRX, SOMX, VRUS, RDUS, REST, VIAC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 29.90 | 7,000 | 209,300 | 7,000 | |
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.07 | 20,311 | 610,843 | 0 | 20.3 K to 0 (-100.00 %) |
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 2,435 | 73,050 | 20,311 | 22.7 K to 20.3 K (-10.71 %) |
Jun 04 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 82,072 | 2,462,160 | 824,255 | 906.3 K to 824.3 K (-9.06 %) |
Jun 03 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 9,935 | 298,050 | 906,327 | 916.3 K to 906.3 K (-1.08 %) |
Jun 03 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 44,582 | 1,337,460 | 916,262 | 960.8 K to 916.3 K (-4.64 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 20,411 | 612,330 | 960,844 | 981.3 K to 960.8 K (-2.08 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 32.14 | 5,300 | 170,342 | 981,255 | 986.6 K to 981.3 K (-0.54 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 31.38 | 74,980 | 2,352,872 | 986,555 | 1.1 M to 986.6 K (-7.06 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.62 | 114,837 | 3,516,309 | 1,061,535 | 1.2 M to 1.1 M (-9.76 %) |
May 23 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 7,340 | 220,200 | 1,176,372 | 1.2 M to 1.2 M (-0.62 %) |
May 21 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 13,550 | 406,500 | 1,183,712 | 1.2 M to 1.2 M (-1.13 %) |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | X | 2.69 | 37,192 | 100,046 | 0 | |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 29.30 | 3,416 | 100,089 | 1,314,255 | 1.3 M to 1.3 M (-0.26 %) |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | X | 2.69 | 37,192 | 100,046 | 1,317,671 | 1.3 M to 1.3 M (+2.90 %) |
Apr 29 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.04 | 6,303 | 189,342 | 1,163,486 | 1.2 M to 1.2 M (-0.54 %) |
Apr 29 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 108,115 | 3,243,450 | 1,169,789 | 1.3 M to 1.2 M (-8.46 %) |
Apr 18 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 2,575 | 77,250 | 1,277,904 | 1.3 M to 1.3 M (-0.20 %) |
Apr 18 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 10,000 | 300,000 | 1,280,479 | 1.3 M to 1.3 M (-0.77 %) |
Mar 19 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 28.44 | 500,000 | 14,220,000 | 2,290,479 | 2.8 M to 2.3 M (-17.92 %) |
Mar 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 27.86 | 500,000 | 13,930,000 | 2,790,479 | 3.3 M to 2.8 M (-15.20 %) |
Jun 06 2012 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 10.81 | 7,000 | 75,670 | 7,000 | |
Nov 22 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 6.50 | 461,538 | 2,999,997 | 3,290,479 | 2.8 M to 3.3 M (+16.31 %) |
Jun 06 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 13.98 | 15,692 | 219,374 | 15,692 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 13.44 | 712,567 | 9,576,900 | 0 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 1,487,680 | 0 | 0 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 7.00 | 267,857 | 1,874,999 | 2,828,941 | 2.6 M to 2.8 M (+10.46 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 7.00 | 267,857 | 1,874,999 | 2,561,084 | 2.3 M to 2.6 M (+11.68 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 712,567 | 0 | 2,293,227 | 1.6 M to 2.3 M (+45.08 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,487,680 | 0 | 1,580,660 | 93 K to 1.6 M (+1,600.00 %) |
Page: 1